These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24359128)

  • 21. Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.
    Roiz-Santiañez R; Suarez-Pinilla P; Crespo-Facorro B
    Curr Neuropharmacol; 2015; 13(4):422-34. PubMed ID: 26412062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics.
    Molina V; Martín C; Ballesteros A; de Herrera AG; Hernández-Tamames JA
    Eur Arch Psychiatry Clin Neurosci; 2011 Sep; 261(6):407-16. PubMed ID: 21191610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and structural brain differences in bipolar disorder: a multimodal meta-analysis of neuroimaging studies.
    Chen G; Wang J; Gong J; Qi Z; Fu S; Tang G; Chen P; Huang L; Wang Y
    Psychol Med; 2022 Oct; 52(14):2861-2873. PubMed ID: 36093787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies.
    Honea R; Crow TJ; Passingham D; Mackay CE
    Am J Psychiatry; 2005 Dec; 162(12):2233-45. PubMed ID: 16330585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.
    van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Mandl RC; Collins DL; Evans AC; Kahn RS
    Neuropsychopharmacology; 2007 Oct; 32(10):2057-66. PubMed ID: 17327887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of menopause on brain structural changes in schizophrenia.
    Fukuta H; Ito I; Tateno A; Nogami T; Taiji Y; Arakawa R; Suhara T; Asai K; Okubo Y
    Psychiatry Clin Neurosci; 2013 Jan; 67(1):3-11. PubMed ID: 23331283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voxel-based morphometric analysis of gray matter in first episode schizophrenia.
    Kubicki M; Shenton ME; Salisbury DF; Hirayasu Y; Kasai K; Kikinis R; Jolesz FA; McCarley RW
    Neuroimage; 2002 Dec; 17(4):1711-9. PubMed ID: 12498745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies.
    Fornito A; Yücel M; Patti J; Wood SJ; Pantelis C
    Schizophr Res; 2009 Mar; 108(1-3):104-13. PubMed ID: 19157788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis of voxel-based morphometric studies of migraine.
    Zhang X; Zhou J; Guo M; Cheng S; Chen Y; Jiang N; Li X; Hu S; Tian Z; Li Z; Zeng F
    J Neurol; 2023 Jan; 270(1):152-170. PubMed ID: 36098838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gray Matter Structural and Functional Alterations in Idiopathic Blepharospasm: A Multimodal Meta-Analysis of VBM and Functional Neuroimaging Studies.
    Zhang M; Huang X; Li B; Shang H; Yang J
    Front Neurol; 2022; 13():889714. PubMed ID: 35734475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter.
    Wang J; Tang Y; Curtin A; Xia M; Tang X; Zhao Y; Li Y; Qian Z; Sheng J; Zhang T; Jia Y; Li C; Wang J
    Brain Stimul; 2019; 12(2):319-328. PubMed ID: 30473477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of aripiprazole and haloperidol on neural activation during the n-back in healthy individuals: A functional MRI study.
    Goozee R; Reinders AATS; Handley R; Marques T; Taylor H; O'Daly O; McQueen G; Hubbard K; Mondelli V; Pariante C; Dazzan P
    Schizophr Res; 2016 Jun; 173(3):174-181. PubMed ID: 25778615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Networks.
    Pievani M; Pini L; Ferrari C; Pizzini FB; Boscolo Galazzo I; Cobelli C; Cotelli M; Manenti R; Frisoni GB
    J Alzheimers Dis; 2017; 57(3):825-843. PubMed ID: 28304293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment.
    Fahim C; Stip E; Mancini-Marïe A; Gendron A; Mensour B; Beauregard M
    J Clin Psychopharmacol; 2005 Aug; 25(4):367-71. PubMed ID: 16012281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural correlates of successful emotional episodic encoding and retrieval: An SDM meta-analysis of neuroimaging studies.
    Dahlgren K; Ferris C; Hamann S
    Neuropsychologia; 2020 Jun; 143():107495. PubMed ID: 32416099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.
    Dazzan P; Morgan KD; Orr K; Hutchinson G; Chitnis X; Suckling J; Fearon P; McGuire PK; Mallett RM; Jones PB; Leff J; Murray RM
    Neuropsychopharmacology; 2005 Apr; 30(4):765-74. PubMed ID: 15702141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.
    Smieskova R; Fusar-Poli P; Allen P; Bendfeldt K; Stieglitz RD; Drewe J; Radue EW; McGuire PK; Riecher-Rössler A; Borgwardt SJ
    Curr Pharm Des; 2009; 15(22):2535-49. PubMed ID: 19689326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
    Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain structural abnormalities as potential markers for detecting individuals with ultra-high risk for psychosis: A systematic review and meta-analysis.
    Ding Y; Ou Y; Pan P; Shan X; Chen J; Liu F; Zhao J; Guo W
    Schizophr Res; 2019 Jul; 209():22-31. PubMed ID: 31104914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.